Drug Profile
Research programme: Candida monoclonal antibodies - Inhibitex
Alternative Names: Candida monoclonal antibodies - InhibitexLatest Information Update: 13 Jul 2009
Price :
$50
*
At a glance
- Originator Inhibitex
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Candidiasis
Most Recent Events
- 13 Jul 2009 Discontinued - Preclinical for Candidiasis in USA (Parenteral)
- 21 Aug 2007 Preclinical development is ongoing
- 21 Aug 2007 This research programme is available for licensing (http://www.inhibitex.com)